Recombinant expression of human cathelicidin (hCAP18/LL-37) in Pichia pastoris

Biotechnology Letters

Volumn 29, Issue 1, 2007, Pages 73-78

  Hong, In Pyo ^a   Lee, Sung Jae ^a   Kim, Yong Seok ^b   Choi, Shin Geon ^a  

^a Kangwon National University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Cathelicidin; Heterologous expression; LL 37; Pichia pastoris

Indexed keywords

DNA; GENETIC ENGINEERING; METABOLITES; MICROBIOLOGY; MOLECULAR WEIGHT;

CATHELICIDIN; HETEROLOGOUS EXPRESSION; LL-37; PICHIA PASTORIS;

PROTEINS;

ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MICROCOCCUS LUTEUS; PICHIA; PROTEIN ENGINEERING;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; HUMANS; MICROCOCCUS LUTEUS; PICHIA; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

MICROCOCCUS LUTEUS; PICHIA PASTORIS;

EID: 33845637789     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-006-9202-8     Document Type: Article

References (23)

1. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jornvall H, Wigzell H, Gudmundsson GH (2000) The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96:3086-3093
2. Bals R, Weiner DJ, Moscioni D, Meegallla RL, Wilson J (1999) Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immunity 67:6084-6089
3. Burrowers OJ, Diamond G, Lee TC (2005) Recombinant expression of Pleurocidin cDNAusing the Pichia pastoris expression system. J Biomed Biotechnol 4:374-384
4. Chen H, Xu Z, Peng L, Fang X, Yin X, Xu N, Cen P (2006) Recent advances in the research and development of human defensins. Peptides 27:931-940
5. Ganz T (2004) Defensins: antimicrobial peptides of vertebrates. C R Biol 327:539-549
6. Hong IP, Anderson S, Choi SG (2006) Evaluation of a new episomal vector based on the GAP promoter for structural genomics in Pichia pastoris. J Microbiol Biotechnol in press
7. Lee C, Williams T, Wong D, Robertson G (2005) An episomal vector for screening mutant gene libraries in Pichia pastoris. Plasmid 54:80-85
8. Lehrer RI, T Ganz (1998) Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 11:23-27
9. Li Y, Li X, Wang G (2006) Cloning, expression, isotope labeling, and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies. Protein Expr Purif 47:498-505
10. Li L, Wang JX, Zhao XF, Kang CJ, Liu N, Xiang JH, Li FH, Sueda S, Kondo H (2005) High level expression, purification, and characterization of the shrimp antimicrobial peptide, Ch-penaeidin, in Pichia pastoris. Protein Exp Purif 39:144-151
11. Lee JH, Kim JH, Hwang SW, Lee WJ, Yoon HK, Lee HS, Hong SS (2000) High-level expression of antimicrobial peptide mediated by a fusion partner reinforcing formation of inclusion bodies. Biochem Biophys Res Commun 277:575-580
12. Macauley-Patrick S, Fazenda ML, McNeil R, Harvey LM (2005) Heterologous protein expression using the Pichia pastoris expression system. Yeast 22:249-270
13. Moon JY, Henzler-Wildman KA, Ramamoorthy A (2006) Expression and purification of a recombinant LL-37 from Escherichia coli. Biochim Biophys Acta in press
14. Piers KL, Brown MH, Hancock REW (1993) Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 134:7-13
15. Reddy KVR, Yedery RD, Aranha C (2004) Antimicrobial peptides: premises and promises. Int J Antimicrobial Agents 24:536-547
16. Sambrook J, Russell DW (2001) Molecular cloning-A laboratory manual. CSHL Press, Cold Spring Harbor, New York
17. Smet KD, Contreras R (2005) Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 27:1337-1347
18. Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, Borregaard N (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97:3951-3959
19. Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, Borregaard N, Rabe KF, Hiemstra PS (2003) The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 171:6690-6696
20. Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray Jr PB, Lehrer RI, Welsh MJ, Tack BF (2000) Bactericidal activity of mammalian cathelicidin-derived peptides. Infection Immun 68:2748-2755
21. Turner J, Cho Y, Dinh NN, Waring AJ (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrobial Agents Chemotherapy 42:2206-2214
22. Waterham H, Digan M, Koutz P, Lair S, Cregg J (1997) Isolation of the Pichia pastoris glyceraldehydes-3-phosphate dehydrogenase gene and regulation and use of its promoter. Gene 186:37-44
23. Yang Y, Zheng G, Li G, Zhang X, Cao Z, Rao Q, Wu K (2004) Expression of bioactive recombinant GSLL-39, a variant of human antimicrobial peptide LL-37, in Escherichia coli. Protein Expr Purif 37:229-235